No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
207 |
4. Check minimum number of eventsNone |
207 |
5. Include endpointsNone |
207 |
6. Filter based on genotype QC (FinnGen only) |
207 |
Control definitions (FinnGen only)
- Control exclude
- AB1_INTESTINAL_INFECTIONS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Amoebiasis
based on the number of shared cases.
Similar with more cases:
- Intestinal infectious diseases
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2264 | 1163 | 1084 |
| Only index persons | 1862 | 978 | 884 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.03 | 0.04 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 35.75 | 39.01 | 31.87 |
| Only index persons | 35.28 | 37.77 | 32.54 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 207 | 119 | 88 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 44.44 | 45.34 | 43.23 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 193
- Matched controls
- 1929
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
73.8
66
*
A06.0
ICD-10 Finland
Acute amoebic dysentery
+∞
47.9
44
*
A06.1
ICD-10 Finland
Chronic intestinal amoebiasis
+∞
27.8
26
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
8.0
19.9
48
77
A06.8
ICD-10 Finland
Amoebic infection of other sites
+∞
19.1
18
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.4
14.0
94
421
P01AB01
ATC
metronidazole; oral, rectal
2.9
11.4
100
518
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
31.8
9.5
12
*
A06.4
ICD-10 Finland
Amoebic liver abscess
+∞
9.4
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
9.1
67
302
UJF32
NOMESCO Finland
Coloscopy
3.0
9.0
59
245
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
+∞
8.4
8
*
00699
ICD-8 Finland
Amoebiasis, Without mention of liver abscess
+∞
8.4
8
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
7.8
7.4
16
22
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
+∞
7.3
7
*
A02BC02
ATC
pantoprazole; systemic
2.3
7.0
126
872
R50.9
ICD-10 Finland
Fever, unspecified
3.1
6.8
38
140
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
3.3
6.5
33
114
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
15.0
6.5
10
7
A10AA02
ATC
NA
8.6
6.4
13
16
R51.80
ICD-10 Finland
Headache
2.9
6.4
40
160
R11
ICD-10 Finland
Nausea and vomiting
4.1
6.4
24
65
N02AX02
ATC
tramadol; systemic, rectal
2.2
6.3
85
505
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
+∞
6.3
6
*
H02AB07
ATC
prednisone; oral
3.2
6.2
32
113
A10AA01
ATC
NA
9.1
6.2
12
14
AA1AD
NOMESCO Finland
CT of head and brain
2.5
6.1
51
241
R06.0
ICD-10 Finland
Dyspnoea
2.4
6.0
55
272
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003327) Ova and parasites identified in Stool by Light microscopy
45
56
9.99
35.15
3.6
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
45
163
3.25
10.02
1.9
3.2
umol/l
4.4
7.5
1.44
36
136
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
127
798
2.53
9.51
5.8
5.8
umol/l
10.1
11.3
1.31
119
749
(3024561) Albumin [Mass/volume] in Serum or Plasma
105
625
2.38
8.59
5.6
4.3
g/l
36.5
36.3
0.11
95
591
(42870588) Differential panel, method unspecified - Blood
90
516
2.32
7.86
8.2
5.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
27
84
3.55
7.56
1.9
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
110
706
2.19
7.10
7.7
6.4
mmol/l
1.2
1.2
0.18
103
651
(36304419) Bacteria [Presence] in Urine
76
430
2.21
6.64
3.9
2.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
52
251
2.43
6.56
3.0
2.5
e6/l
1.0
0.7
0.22
24
144
(3030467) Casts [#/volume] in Urine by Automated count
76
435
2.18
6.41
3.9
2.8
e6/l
0.2
0.3
0.14
53
320
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
102
655
2.10
6.37
2.6
2.2
nmol/l
75.7
77.4
0.22
95
580
(3013139) Helicobacter pylori Ag [Presence] in Stool
29
105
3.05
6.37
1.5
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
49
235
2.42
6.25
3.0
2.6
e6/l
1.5
2.5
0.41
21
128
(3018095) Leukocytes [#/volume] in Urine
91
563
2.10
6.25
4.7
3.3
e6/l
79.5
91.3
0.10
61
384
(40758558) Short blood count panel - Blood
72
409
2.17
6.15
5.9
6.7
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
119
818
2.07
6.10
8.1
5.9
e9/l
0.0
0.0
0.04
103
706
(3013115) Eosinophils [#/volume] in Blood
122
847
2.07
6.08
8.1
6.1
e9/l
0.2
0.2
0.17
110
739
(3019069) Monocytes/100 leukocytes in Blood
114
773
2.06
6.05
8.6
6.3
%
8.7
8.3
0.63
105
717
(3006504) Eosinophils/100 leukocytes in Blood
113
766
2.05
5.97
8.4
5.9
%
3.0
2.8
0.57
104
706
(3018010) Neutrophils/100 leukocytes in Blood
115
785
2.05
5.96
7.7
5.9
%
56.5
56.6
0.04
107
730
(3022096) Basophils/100 leukocytes in Blood
110
739
2.04
5.96
8.5
6.1
%
0.7
0.7
0.39
100
678
(3018418) pH of Serum or Plasma
79
472
2.09
5.88
3.7
3.2
ph
7.4
7.4
0.34
14
95
(3002030) Lymphocytes/100 leukocytes in Blood
116
797
2.04
5.87
8.4
6.0
%
29.4
29.0
0.14
107
737
(3001604) Monocytes [#/volume] in Blood
118
816
2.04
5.87
8.2
5.9
e9/l
0.6
0.6
0.03
102
702
(3019198) Lymphocytes [#/volume] in Blood
121
845
2.04
5.84
8.2
5.9
e9/l
1.9
2.0
0.40
106
741
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
81
492
2.06
5.74
3.1
2.4
u/l
56.1
58.8
0.30
73
451
(3013650) Neutrophils [#/volume] in Blood by Automated count
132
956
2.05
5.71
10.7
9.6
e9/l
4.0
4.0
0.04
113
830
(3015736) pH of Urine
94
608
2.00
5.55
4.1
3.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
31
126
2.72
5.52
9.6
9.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
33
139
2.63
5.48
3.9
5.5
mmol/l
2.1
2.2
0.06
28
109
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
85
3.06
5.46
1.9
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
82
511
2.00
5.34
3.5
3.2
u/l
30.5
28.5
0.43
77
488
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
16
44
3.86
5.32
1.4
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
78
480
2.00
5.24
3.9
2.9
e6/l
22.4
70.8
1.57
54
360
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
87
557
1.97
5.22
4.2
2.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
112
782
1.94
5.19
8.6
6.6
mmol/l
1.2
1.2
0.84
96
658
(3014765) Yersinia sp identified in Stool by Organism specific culture
16
45
3.77
5.16
1.4
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
16
45
3.77
5.16
1.4
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
75
461
1.98
5.02
1.9
2.1
u/l
134.2
328.0
0.76
67
433
(3011397) Hemoglobin [Presence] in Urine by Test strip
59
336
2.06
4.86
4.5
3.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
143
1101
1.97
4.78
5.9
3.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
32
142
2.48
4.77
3.9
5.4
kpa
6.1
5.9
0.43
32
137
(3019309) Folate [Moles/volume] in Red Blood Cells
47
251
2.13
4.56
1.9
1.7
nmol/l
1056.6
1285.2
1.02
38
187
(3026493) Urate [Moles/volume] in Serum or Plasma
65
393
1.95
4.49
4.2
2.8
umol/l
9823.3
4983.2
0.21
53
335
(40768797) Stomach Pathology biopsy report
41
211
2.18
4.36
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
22
86
2.74
4.21
1.5
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
13
7.18
4.21
3.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
51
291
2.00
4.13
3.7
2.6
mosm/kgh2o
529.5
575.6
0.54
44
241
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
112
2.51
4.12
1.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
109
794
1.79
4.08
6.7
4.6
estimate
0.0
0.0
0.50
18
154
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
14
6.66
4.03
3.1
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
87
597
1.79
3.96
2.1
1.8
pmol/l
97.8
97.7
0.01
42
304
(3009261) Glucose [Presence] in Urine by Test strip
109
799
1.77
3.95
4.9
3.4
estimate
0.0
0.0
0.00
18
148
(3035350) Ketones [Presence] in Urine by Test strip
107
781
1.77
3.93
4.7
3.4
estimate
0.0
0.0
0.00
18
155
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
65
409
1.86
3.92
1.4
1.4
u/ml
0.6
1.3
1.52
11
104
(3014111) Lactate [Moles/volume] in Serum or Plasma
27
122
2.40
3.87
10.2
9.5
mmol/l
2.0
1.1
0.47
27
117
(3000570) Elastase.pancreatic [Mass/mass] in Stool
14
44
3.34
3.85
2.0
1.4
ug/g
230.6
342.8
—
8
23
(3026008) Bacteria identified in Urine by Culture
70
455
1.81
3.78
2.7
2.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
157
1295
1.88
3.69
4.1
3.8
pmol/l
14.9
14.7
0.43
143
1170
(3023368) Bacteria identified in Blood by Culture
58
359
1.86
3.65
5.3
4.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
79
544
1.73
3.46
3.5
2.9
mmol/l
2.3
2.4
0.38
65
479
(3007853) Bacteria identified in Skin by Aerobe culture
33
171
2.11
3.43
1.9
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
47
277
1.90
3.43
2.8
2.9
mmol/l
2.4
2.4
0.63
40
243
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
151
1245
1.79
3.38
9.2
6.4
u/l
79.1
82.6
0.47
144
1156
(3032080) INR in Blood by Coagulation assay
83
592
1.67
3.13
6.4
8.4
inr
1.1
1.2
0.78
22
186
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
128
2.18
3.07
1.3
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
51
320
1.79
3.03
3.4
2.5
e6/l
4.0
5.1
0.60
44
277
(3012516) Albumin [Mass/volume] in Urine
60
395
1.73
3.02
3.4
3.1
mg/l
54.2
225.7
0.49
42
255
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
5
10.20
2.99
1.2
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
30
3.45
2.94
1.1
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
57
375
1.72
2.87
2.0
1.4
g/l
2.0
2.4
0.65
28
219
(3009508) Creatinine [Moles/volume] in Urine
65
449
1.65
2.71
3.6
3.0
mmol/l
5.9
7.9
4.06
58
375
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
186
1679
2.06
2.60
19.5
11.8
mg/l
23.3
21.9
0.21
157
1260
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
56
2.61
2.59
1.2
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
7
7.28
2.56
1.2
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
11
5.58
2.56
1.0
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
44
278
1.74
2.54
2.9
2.9
ng/l
116.7
135.1
0.09
33
206
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
26
139
2.00
2.50
2.5
2.4
g/l
0.2
0.2
0.10
20
130
(3016018) Differential panel - Cerebral spinal fluid
6
12
5.11
2.42
1.2
3.8
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
8
6.37
2.38
1.2
1.0
%
92.2
97.5
—
5
8
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
28
3.31
2.33
1.3
1.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
28
3.31
2.33
1.4
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
47
311
1.66
2.28
1.6
1.7
pmol/l
431.9
469.1
0.33
40
260
(3020682) Albumin/Creatinine [Ratio] in Urine
60
423
1.59
2.26
4.3
3.9
mg/mmol
17.2
8.3
0.64
39
265
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
29
3.20
2.25
1.4
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
53
368
1.59
2.12
2.3
2.0
mg/l
2.5
2.9
1.01
40
308
(3044290) Cell count panel - Cerebral spinal fluid
8
25
3.29
2.12
1.4
2.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
10
5.09
2.08
1.2
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
63
2.31
2.06
6.5
17.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
48
330
1.59
2.00
1.6
1.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
64
2.27
1.99
2.1
2.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
5
11
4.63
1.95
1.6
5.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
11
4.63
1.95
2.4
2.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
16
3.83
1.95
1.5
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
171
1542
1.63
1.90
5.4
4.5
mu/l
1.7
2.7
0.61
161
1396
(3013826) Glucose [Moles/volume] in Serum or Plasma
112
928
1.45
1.88
6.9
5.1
mmol/l
6.9
6.6
0.63
107
847
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
19
101
1.97
1.88
7.4
8.7
mmol/l
24.7
25.1
0.10
19
101
(3049717) Cytology report of Urine Cyto stain
10
40
2.58
1.86
2.2
2.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
50
353
1.55
1.85
2.5
2.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
17
3.60
1.85
1.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
29
2.83
1.81
1.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
81
2.06
1.80
2.6
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
28
172
1.73
1.79
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
25
149
1.77
1.76
1.3
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48
340
1.54
1.75
1.6
1.9
mg/l
0.9
1.1
0.42
32
264
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
24
142
1.78
1.74
1.7
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
24
2.98
1.74
1.0
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
24
2.98
1.74
1.0
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
24
2.98
1.74
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
24
2.98
1.74
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
48
2.36
1.73
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
188
0.46
1.72
1.2
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
134
1160
1.44
1.71
3.3
3.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
58
430
1.48
1.71
5.7
3.7
estimate
0.0
0.0
0.50
18
152
(3044640) Blood type and Crossmatch panel - Blood
64
484
1.47
1.71
2.7
2.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
93
755
1.42
1.70
12.0
8.8
e9/l
0.0
0.0
0.93
74
617
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
43
2.39
1.63
1.4
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
14
3.63
1.62
1.2
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
32
2.56
1.61
2.0
9.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
31
203
1.62
1.57
3.0
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
49
357
1.49
1.56
1.6
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
16
3.18
1.44
1.4
1.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
87
716
1.37
1.40
3.1
2.5
ug/l
117.0
101.4
0.25
82
658
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
152
1.65
1.39
3.5
3.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
41
2.25
1.39
1.1
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
68
1.97
1.36
1.4
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
17
2.99
1.36
1.8
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
76
615
1.37
1.35
5.5
3.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
114
1.73
1.33
1.4
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
204
1.55
1.32
1.5
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
19
115
1.72
1.30
3.1
3.1
ml/min/173m2
65.2
66.2
—
8
49
(3045414) Leukocytes [Presence] in Urine
11
55
2.06
1.30
1.4
1.7
—
—
—
0
0
(4062490)
5
18
2.82
1.29
5.6
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
63
1.96
1.25
1.9
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
56
2.02
1.24
1.3
2.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
49
2.09
1.24
1.2
1.3
—
—
—
0
0
(4010399)
19
117
1.69
1.23
1.4
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
71
1.89
1.22
4.3
2.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
19
2.67
1.22
1.8
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
169
1564
1.44
1.21
3.7
3.8
mmol/l
1.3
1.3
0.07
158
1431
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
142
1.61
1.20
1.8
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
21
134
1.63
1.20
2.6
3.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
20
2.54
1.16
2.2
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
20
2.54
1.16
1.8
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
20
2.54
1.16
2.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
20
2.54
1.16
2.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
20
2.54
1.16
1.8
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
28
194
1.51
1.14
1.4
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
53
415
1.37
1.14
1.9
1.6
mmol/l
1.5
1.4
0.51
48
346
(3037522) Nuclear Ab [Titer] in Serum
33
237
1.47
1.14
1.5
1.3
titre
346.7
324.6
—
9
52
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
16
96
1.72
1.14
5.1
3.2
kpa
5.2
5.2
0.20
16
86
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
30
2.38
1.13
2.0
2.6
mg/l
10.6
10.2
—
7
30
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
39
290
1.42
1.13
1.4
1.3
iu/ml
32.9
25.9
—
8
101
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
86
727
1.31
1.11
4.9
4.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
168
1561
1.40
1.11
19.7
12.8
%
40.0
40.4
0.34
132
1182
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
21
2.41
1.09
1.4
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
46
2.00
1.05
1.0
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
7
34
2.09
1.04
3.9
3.4
mg/l
45.7
25.5
—
7
28
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
34
2.09
1.04
1.6
2.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
7
34
2.09
1.04
3.9
3.3
mg/l
59.7
257.5
—
7
28
(3028707) Methadone [Presence] in Urine by Screen method
7
34
2.09
1.04
1.3
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
9
47
1.96
1.03
4.2
9.6
mg/l
1.8
1.4
—
9
41
(3003396) Base excess in Arterial blood by calculation
22
149
1.53
1.00
12.8
11.7
mmol/l
-0.7
1.7
0.76
17
128
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
36
1.98
0.98
1.0
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
210
1.44
0.97
1.8
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
126
1134
1.28
0.97
3.3
2.9
u/l
55.9
46.9
0.46
120
1066
(3021960) Folate [Moles/volume] in Serum or Plasma
48
381
1.34
0.95
1.7
1.4
nmol/l
22.1
21.9
0.04
41
319
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
27
2.26
0.94
1.5
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
27
2.26
0.94
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
70
587
1.29
0.94
3.7
3.2
ng/l
33.9
42.7
0.29
53
398
(3044889) 12 lead EKG panel
123
1107
1.27
0.93
3.9
3.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
44
346
1.35
0.92
4.8
3.7
kg/l
1.0
1.0
—
7
33
(3027008) Opiates [Presence] in Urine
12
71
1.73
0.91
1.3
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
71
1.73
0.91
1.3
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
71
1.73
0.91
1.3
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
79
1.69
0.90
2.8
4.9
%
0.9
1.4
1.92
13
79
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
95
1.62
0.90
1.3
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
30
2.03
0.87
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
52
629
0.77
0.87
2.6
2.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
72
1.71
0.87
1.3
1.6
—
—
—
0
0
(4094501)
8
44
1.85
0.87
1.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
14
88
1.63
0.87
1.5
1.2
u/ml
230.3
162.7
0.19
14
81
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
160
1495
1.31
0.86
6.1
5.3
mmol/mol
39.7
39.3
0.19
150
1378
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
49
396
1.31
0.86
3.3
3.2
ng/l
1214.6
1059.3
0.13
42
330
(40768443) Skin Pathology biopsy report
10
57
1.79
0.85
1.5
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
31
1.96
0.85
1.5
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
32
1.90
0.82
9.8
3.9
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
15
98
1.57
0.81
17.9
9.7
%
1.2
1.5
0.62
15
98
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
15
98
1.57
0.81
17.9
10.1
%
0.7
0.7
0.22
15
98
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
33
1.84
0.79
1.5
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
67
1.68
0.76
1.4
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
24
2.11
0.75
1.6
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
38
1.87
0.74
1.6
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
38
1.87
0.74
1.3
3.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
38
1.87
0.74
1.0
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
9
56
1.63
0.73
1.4
1.7
g/l
2.2
1.5
—
9
48
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
12
76
1.61
0.73
1.3
2.1
mg/l
6.5
3.1
—
6
58
(40768804) Tissue Pathology biopsy report
71
613
1.24
0.73
2.0
2.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
25
2.02
0.73
1.4
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
25
2.02
0.73
2.8
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
40
1.78
0.72
3.0
3.1
mmol/l
24.0
25.1
—
7
32
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
26
1.95
0.71
1.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
20
145
1.42
0.69
4.9
3.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
163
1542
1.27
0.68
17.5
11.1
ml/min/173m2
84.3
83.9
0.08
136
1253
(3000492) Spirometry study
20
146
1.41
0.66
1.2
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
95
1.51
0.66
1.6
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
29
1.74
0.64
2.0
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
185
1783
1.35
0.63
13.9
9.3
u/l
28.1
25.8
0.33
180
1715
(3002179) Metamyelocytes/100 leukocytes in Blood
17
122
1.43
0.62
4.9
5.0
%
0.1
0.5
—
7
26
(3002523) Influenza virus A Ag [Presence] in Specimen
5
30
1.68
0.62
1.0
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
30
1.68
0.62
2.2
8.9
%
58.3
65.7
—
5
30
(3021901) Oxygen saturation in Capillary blood
5
30
1.68
0.62
5.0
3.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
30
1.68
0.62
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
51
1.59
0.61
1.5
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
27
211
1.32
0.61
1.9
1.7
%
1.5
1.4
0.23
22
188
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
284
1.28
0.61
1.5
1.3
u/ml
3.7
12.3
1.11
11
109
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
173
0.67
0.60
1.4
1.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
22
0.00
0.59
0.0
1.5
—
91.5
—
0
22
(3028626) Oxygen [Partial pressure] in Capillary blood
8
54
1.50
0.58
4.8
3.3
kpa
8.9
8.6
—
8
47
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
73
1.54
0.57
4.7
2.9
%
48.4
49.5
0.05
11
73
(3027315) Oxygen [Partial pressure] in Blood
6
36
1.69
0.57
8.8
2.6
kpa
7.6
8.8
—
6
36
(3019060) Gas panel - Arterial blood
13
90
1.47
0.57
4.8
10.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
126
1.38
0.53
4.6
5.2
%
0.0
0.3
—
7
31
(40760892) CBC W Ordered Manual Differential panel - Blood
46
394
1.22
0.51
5.5
5.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
182
1762
1.27
0.49
16.8
11.1
—
—
—
0
0
(3002256) Pathology report gross observation
26
211
1.27
0.46
1.4
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
95
1.39
0.45
3.6
2.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
169
1628
1.21
0.45
4.5
4.2
mmol/l
4.6
4.7
0.27
158
1506
(3034770) Mitochondria Ab [Titer] in Serum
7
51
1.39
0.44
1.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
168
1618
1.20
0.44
4.5
4.1
mmol/l
1.5
1.5
0.11
158
1485
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
31
1.63
0.43
4.8
3.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
17
132
1.31
0.42
5.1
5.1
%
0.1
0.2
—
7
36
(3005570) Glucose [Moles/volume] in Urine
0
15
0.00
0.41
0.0
2.6
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
16
0.00
0.41
0.0
1.7
—
7.4
—
0
7
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(4281824)
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
8
60
1.35
0.41
1.8
1.7
nmol/l
29.9
40.2
—
8
60
(4035726)
10
137
0.72
0.40
1.3
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
18
0.00
0.40
0.0
3.7
—
74.3
—
0
18
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
28
234
1.23
0.40
2.0
2.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
5
36
1.40
0.38
9.8
2.6
kpa
4.6
4.9
—
5
36
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
218
1.22
0.36
1.8
2.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
41
1.48
0.36
2.2
4.4
%
148.5
168.7
—
6
41
(3035941) MCH [Entitic mass]
192
1881
1.29
0.36
27.4
17.8
pg
30.2
30.2
0.13
192
1852
(3024731) MCV [Entitic volume]
192
1881
1.29
0.36
27.5
17.8
fl
90.5
90.6
0.14
192
1852
(3041096) Erythrocytes [Presence] in Urine by Automated
51
459
1.15
0.33
5.0
3.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
170
1651
1.17
0.33
5.0
4.6
mmol/l
2.7
2.8
0.28
160
1517
(3000963) Hemoglobin [Mass/volume] in Blood
192
1884
1.26
0.32
27.8
17.9
g/l
133.6
136.3
1.76
192
1855
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
54
1.31
0.30
2.0
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
55
1.28
0.30
1.0
1.1
—
14.6
—
0
13
(4034850)
7
56
1.26
0.29
11.0
10.7
—
—
—
0
0
(3020891) Body temperature
8
63
1.28
0.28
10.0
5.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
187
1.20
0.28
4.4
4.4
%
28.1
32.0
0.80
15
120
(3017181) Myelocytes/100 leukocytes in Blood
17
141
1.22
0.27
5.2
4.9
%
0.4
1.0
—
7
41
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
72
1.26
0.26
2.6
1.5
mu/l
417.0
308.6
—
9
67
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
255
1.16
0.26
1.5
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
44
481
0.89
0.24
1.5
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
41
1.22
0.22
5.0
4.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
11
0.00
0.21
0.0
4.3
—
—
—
0
0
(3000012) Reticulocyte production index
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
1.0
—
0
10
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
14
117
1.21
0.21
4.1
3.7
e9/l
71.6
69.0
—
9
92
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
30
270
1.13
0.20
3.5
2.8
ug/l
0.6
0.7
0.16
22
169
(3019225) pH of Specimen
17
146
1.18
0.20
6.9
3.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
58
1.21
0.18
1.4
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
121
0.82
0.18
1.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
29
263
1.12
0.17
1.6
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
73
1.10
0.16
3.9
3.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
9
79
1.15
0.15
1.9
3.0
e6/l
0.3
0.1
—
9
73
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
15
132
1.15
0.13
1.7
2.2
ug/l
3.4
5.8
0.97
15
116
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
15
135
1.12
0.10
4.8
3.4
mmol/l
1.3
1.2
1.62
15
121
(3019832) Treponema pallidum Ab [Presence] in Serum
15
165
0.90
0.09
1.4
1.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
162
1600
1.06
0.09
4.4
4.2
mmol/l
6.0
5.8
0.87
144
1462
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
55
1.09
0.09
1.3
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
1.2
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
7
67
1.05
0.08
2.1
2.2
u/l
53.0
41.5
—
7
61
(1002224) Polysomnography panel
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
94
0.85
0.07
1.3
1.7
—
—
—
0
0
(3013512) EKG study
46
444
1.05
0.06
4.2
3.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
47
454
1.05
0.06
5.6
4.4
ug/l
1.6
1.8
0.23
42
394
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
38
365
1.05
0.06
4.0
4.0
%
25.1
22.9
0.24
16
163
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
19
181
1.05
0.03
14.2
6.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
209
0.95
0.03
1.7
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
165
0.97
0.00
1.9
1.7
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.1
—
8.2
—
0
9
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
5
0.00
0.00
0.0
4.4
—
154.1
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
10.6
—
7.7
—
0
5
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
209.9
—
0
9
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
87
0.92
0.00
1.3
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.2
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
5
52
0.96
0.00
6.0
3.8
g/l
0.3
0.2
—
5
20
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
4.7
—
45.8
—
0
6
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
56.8
—
0
8
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_AMOEBIASIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_AMOEBIASIS | 1.655 [1.34, 2.04] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.218 |
During the follow-up period (1.1.1998 — 31.12.2019), 241 out of 965 females with AB1_AMOEBIASIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_AMOEBIASIS | 1.981 [1.42, 2.76] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 202 out of 870 males with AB1_AMOEBIASIS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_AMOEBIASIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.174% | 0.37% |
| 5 | 0.862% | 2.264% |
| 10 | 2.187% | 5.55% |
| 15 | 4.515% | 10.558% |
| 20 | 7.752% | 17.621% |
Relationships between endpoints
↥Index endpoint: AB1_AMOEBIASIS – Amoebiasis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data